Antitrust & Competition Policy Blog

Editor: D. Daniel Sokol
University of Florida
Levin College of Law

Wednesday, June 24, 2009

FTC Issues Interim Report on "Authorized Generic" Drugs

Posted by D. Daniel Sokol

From the FTC press release:

  • The Federal Trade Commission today issued “Authorized Generics: An Interim Report,” which presents the first set of results from a study conducted to examine the short-term and long-term effects of “authorized generics” on competition in the prescription drug marketplace. An authorized generic exists when a pharmaceutical manufacturer sells a drug under both a brand-name and generic label. The FTC conducted the study in response to requests from Congress. Issues related to generic drug competition are relevant to current legislative debates and health care reform.

You can download the report here.

| Permalink

TrackBack URL for this entry:

Listed below are links to weblogs that reference FTC Issues Interim Report on "Authorized Generic" Drugs:


Post a comment